Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Trending Now
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Ağustos 27, 2025
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
OCT changes with low-level red light therapy for myopia in children
Ağustos 26, 2025
Alcon presenting at APACRS 2025
Ağustos 21, 2025
Breaking News
Popular Now
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
Collaborate With Us
Join forces with Ophthalmology News to reach a global community of eye care professionals. Whether you want to contribute an article, share research, or explore partnership opportunities, we’d love to hear from you.
Editor Choice
FDA Approves XDEMVY for Demodex Blepharitis
Tarsus Pharmaceuticals has received FDA approval for XDEMVY(TM) (lotilaner ophthalmic solution) 0.25%…
Study Finds Key Genes Linked to Primary Open-Angle Glaucoma
In a recent study published in Nature Communications, researchers from Mass Eye…
Lupin Launches Bromfenac Ophthalmic Solution in the US
Lupin Limited announced the launch of Bromfenac Ophthalmic Solution, 0.075%. The product…
ESCRS Winter Meeting Starts with Dynamic Program
The European Society of Cataract and Refractive Surgeons (ESCRS) has commenced its…
Opthea Completes Enrollment for Wet AMD Trial
Opthea has reached a significant milestone in its quest to combat wet…
VSY Biotechnology’s 100% Glistening-Free IOL Material
VSY Biotechnology GmbH is pushing the boundaries of ophthalmology with its cutting-edge…
A Novel Approach To Trifocal IOLs
AcrivaUD Trinova is the world’s first and only sinusoidal trifocal IOL manufactured…
Dry Eye Treatment & Cyclosporine and Side Effect in Dogs
Dry eye disease (DED), also known as keratoconjunctivitis sicca (KCS), is a…
Survey Results: Top OVD Producers in the Market
Ophthalmic viscosurgical devices (OVDs) play an important role in the development of…
Worth Reading
Meeting expectations with evolving technology
Ağustos 26, 2025
/ Patient Education, Research & Studies, Technology & Innovation, Treatments & Surgery
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Ağustos 26, 2025
/ Industry News, Patient Education, Research & Studies, Treatments & Surgery
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Ağustos 26, 2025
/ Patient Education, Research & Studies
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
/ Patient Education, Research & Studies, Treatments & Surgery
Subscribe Now
Enter your email address below and subscribe to our newsletter